Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
GlaxoSmithKline Flovent Approved in USA and EURespiratory system
Sanofi-aventis Flisint Submitted for approval in USAAlimentary tract & metabolism
Baxter International FLEXBUMIN Approved in USABlood & blood forming organs
Paladin Labs Fidelin Submitted for approval in USASystemic hormonal preparations
Procyon Biopharma Fibrostat discontinuedDermatologicals
Draximage Fibrimage in Phase III 
Neurochem Fibrillex Submitted for approval in USAAlimentary tract & metabolism
Apotex Ferriprox Approved in USA and EUBlood & blood forming organs
LAB International Fentanyl TAIFUN accomplished Phase IINervous system
GlaxoSmithKline Fendrix Approved in USAAnti-infectives for systemic use
Warner Chilcott Femring Approved in USAGenito urinary system & sex hormones
NexMed Femprox in Phase IIIGenito urinary system & sex hormones
Roche Femara Approved in USA and GermanyAntineoplastic & immunomodulating agents
Novartis Femara Approved in EU and USAAntineoplastic & immunomodulating agents
Novartis Femara Approved in EU and USAAntineoplastic & immunomodulating agents
Sanofi-aventis Fasturtec Approved in USAGenito urinary system & sex hormones
AstraZeneca Faslodex Approved in USA and EUAntineoplastic & immunomodulating agents
Acorda Therapeutics Fampridine-SR accomplished Phase IIINervous system
Acorda Therapeutics Fampridine-SR in Phase IIINervous system
Oscient Factive Approved in USAAnti-infectives for systemic use
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.